Key Patents Issued to Celerus Diagnostics  
11/18/2011 10:06:50 AM

CARPINTERIA, Calif.--(BUSINESS WIRE)--Celerus Diagnostics, developer of the Wave RPD System and global leader in rapid immunohistochemistry (“IHC”) for cancer diagnosis, announced today that the Company has been issued three important patents by the United States Patent and Trademark Office. Issuance of the patents, covering key technologies that enable proprietary Rapid IHC®, puts the company on pace in its pursuit of global patent coverage for its revolutionary technologies.